Skip to main content
Premium Trial:

Request an Annual Quote

Time to Speak Up

If you've got a few free minutes and a desire to share how you feel about direct-to-consumer genomic testing, head on over here for a survey that's part of Sudeepa Abeysinghe's doctoral research at the Australian National University. According to the survey's introduction, "The study aims to gain an appreciation of users’ experiences and perspectives of direct-to-consumer genomic testing. This will aid in achieving a greater understanding of the utilization and impact of these tests within society generally."

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.